Vicarious Surgical (NYSE:RBOT – Get Free Report) is set to announce its earnings results after the market closes on Monday, April 29th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last posted its earnings results on Monday, March 4th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.05. During the same period last year, the firm earned ($0.16) earnings per share. On average, analysts expect Vicarious Surgical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Vicarious Surgical Price Performance
Shares of Vicarious Surgical stock opened at $0.27 on Friday. The firm has a market cap of $47.45 million, a price-to-earnings ratio of -0.55 and a beta of 1.18. The stock’s 50-day moving average is $0.33 and its 200-day moving average is $0.37. Vicarious Surgical has a one year low of $0.20 and a one year high of $2.46.
Analyst Upgrades and Downgrades
Read Our Latest Report on Vicarious Surgical
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Featured Articles
- Five stocks we like better than Vicarious Surgical
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 4/22 – 4/26
- Trading Halts Explained
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.